PDK1 Mediates <i>NOTCH1</i> -Mutated Head and Neck Squamous Carcinoma Vulnerability to Therapeutic PI3K/mTOR Inhibition
Vaishnavi Sambandam(National Comprehensive Cancer Network), Faye M. Johnson(The University of Texas MD Anderson Cancer Center), Tuhina Mazumdar(The University of Texas MD Anderson Cancer Center), Chenfei Huang(Baylor College of Medicine), Curtis R. Pickering(The University of Texas MD Anderson Cancer Center), Xiayu Rao(The University of Texas MD Anderson Cancer Center), Mitchell J. Frederick(The University of Texas MD Anderson Cancer Center), Jing Wang(The University of Texas MD Anderson Cancer Center), Li Shen(The University of Texas MD Anderson Cancer Center), Pan Tong(The University of Texas MD Anderson Cancer Center), Qiuli Li(Sun Yat-sen University), Jeffery N. Myers(The University of Texas MD Anderson Cancer Center), Shaohua Peng(The University of Texas MD Anderson Cancer Center), Ratnakar Singh(University of Illinois Urbana-Champaign)
Cited by 51
Related Papers
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in <i>NOTCH1</i>
|Science|2011|1.7k
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
|Cancer Cell|2021|930
Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas
|Science Translational Medicine|2015|502
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC
|Cancer Discovery|2023|181
Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates
|Nature Communications|2016|159